Characteristics | Non-endemic N = 527 | Endemic N = 667 | P-value |
---|---|---|---|
Age | |||
< 50 | 29 | 47 | < 0.001 |
50 ~ 59 | 74 | 111 | |
60 ~ 69 | 139 | 210 | |
> 70 | 259 | 237 | |
Sex | |||
Male | 222 | 298 | 0.377 |
Female | 305 | 369 | |
Smoking | |||
Yes | 192 | 251 | 0.865 |
No | 69 | 41 | |
ESRD | |||
Yes | 105 | 63 | < 0.001 |
No | 156 | 223 | |
Non UC tumor | |||
Yes | 54 | 46 | 0.063 |
No | 469 | 602 | |
Previous bladder tumor | |||
Yes | 30 | 54 | < 0.017 |
No | 231 | 232 | |
Tumor location | |||
Renal pelvis | 369 | 367 | < 0.001 |
Upper ureter | 111 | 117 | 0.241 |
Middle ureter | 60 | 98 | 0.049 |
Distal ureter | 103 | 140 | 0.317 |
Bladder cuff | 7 | 13 | 0.354 |
Tumor size | |||
non-visible | 7 | 3 | 0.138 |
< 1 cm | 87 | 22 | |
≥ 1 & < 2 cm | 95 | 43 | |
≥ 2 & < 3 cm | 98 | 45 | |
≥ 3 cm | 214 | 108 | |
Tumor grade | |||
low grade | 63 | 44 | 0.157 |
high grade | 340 | 320 | |
Pathologic staging | |||
stage 0a/0is | 43 | 113 | < 0.001 |
stage I | 106 | 150 | |
stage II | 112 | 119 | |
stage III | 125 | 137 | |
stage IV | 30 | 98 | |
Treatment options | |||
NxUx | 420 | 603 | 0.001 |
Segmental resection | 1 | 14 | |
Endoscopic | 86 | 9 | |
Adjuvant chemotherapy | 53 | 61 | 0.153 |
No operation | 22 | 41 | |
Pre-op mean renal function (eGFR) | 37.185 | 39.216 | 0.87 |